Arrowhead Pharmaceuticals Inc. buy Bank of America Co.
Start price
02.01.24
/
50%
€28.47
Target price
02.01.25
€33.76
Performance (%)
-25.50%
Price
22:26
€21.21
Summary
This prediction is currently active. The price of Arrowhead Pharmaceuticals Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -25.50%. This prediction currently runs until 02.01.25. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Arrowhead Pharmaceuticals Inc. | -3.959% | -3.959% |
| iShares Core DAX® | 0.961% | -2.210% |
| iShares Nasdaq 100 | 2.626% | -1.918% |
| iShares Nikkei 225® | 0.217% | -7.216% |
| iShares S&P 500 | 1.540% | -1.858% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its price target raised by analysts at Bank of America Co. from $29.00 to $37.00. They now have a "buy" rating on the stock.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€21.76
04.12.23
04.12.23
€26.71
04.12.24
04.12.24
-0.92%
22:26
22:26
